Irina Koffler | LifeSci Advisors |
Spiro Rombotis | President & Chief Executive Officer |
Mark Kirschbaum | Senior Vice President & Chief Medical Officer |
Paul McBarron | Executive Vice President, Finance & Chief Operating Officer |
Ahu Demir | Ladenburg |
Jonathan Aschoff | ROTH Capital Partners |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals Third Quarter 2022 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions] The company will also be accepting a limited number of questions submitted via e-mail to address ir@cyclacel.com. [Operator Instructions] Please note, today's call is being recorded. I would now like to turn the conference call over to the company.